[Translation] To evaluate the safety, tolerability, pharmacokinetics and immunogenicity of GB002 recombinant polypeptide inhalation solution in randomized, double-blind, placebo-controlled, dose-escalating single and multiple administrations in Chinese healthy adult subjects Phase I clinical study of
主要目的
评价健康受试者单次/多次吸入不同剂量GB002重组多肽的安全性和耐受性。
次要目的
1 )评价健康受试者单次 / 多次吸入不同剂量 GB002 重组多肽 的 药 代 动 力 学
(Pharmacokinetics,PK,简称药动学)特征;
2)评价健康受试者单次/多次吸入不同剂量GB002重组多肽后的免疫原性。
[Translation] main purpose
To evaluate the safety and tolerability of single/multiple inhalation of different doses of GB002 recombinant polypeptide in healthy subjects.
secondary purpose
1) Evaluate the pharmacokinetics of single/multiple inhalation of different doses of GB002 recombinant polypeptide in healthy subjects
(Pharmacokinetics, PK, referred to as pharmacokinetics) characteristics;
2) Evaluate the immunogenicity of healthy subjects after single/multiple inhalation of different doses of GB002 recombinant polypeptide.